Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma.
Yamamoto C, Minakata D, Koyama S, Sekiguchi K, Fukui Y, Murahashi R, Nakashima H, Matsuoka S, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Nagayama T, Umino K, Nakano H, Morita K, Yamasaki R, Ashizawa M, Ueda M, Hatano K, Sato K, Ohmine K, Fujiwara SI, Kanda Y. Yamamoto C, et al. Among authors: ohmine k. Blood. 2022 Aug 11;140(6):594-607. doi: 10.1182/blood.2021015220. Blood. 2022. PMID: 35580269 Free PMC article.
Pleocytosis after hemopoietic stem cell transplantation.
Nagashima T, Muroi K, Kawano-Yamamoto C, Miyoshi T, Tatara R, Meguro A, Fujiwara S, Obara Y, Oh I, Kikuchi S, Sato K, Matsuyama T, Toshima M, Ohmine K, Ozaki K, Takatoku M, Mori M, Nagai T, Ozawa K. Nagashima T, et al. Among authors: ohmine k. Leuk Lymphoma. 2006 Aug;47(8):1613-7. doi: 10.1080/10428190600625836. Leuk Lymphoma. 2006. PMID: 16966274
Long-term results of dose-intensive chemotherapy with G-CSF support (TCC-NHL-91) for advanced intermediate-grade non-Hodgkin's lymphoma: a review of 59 consecutive cases treated at a single institute.
Akutsu M, Tsunoda S, Izumi T, Tanaka M, Katano S, Inoue K, Igarashi S, Hirabayashi K, Furukawa Y, Ohmine K, Sato K, Kobayashi H, Ozawa K, Kirito K, Nagashima T, Teramukai S, Fukushima M, Kano Y. Akutsu M, et al. Among authors: ohmine k. Oncol Res. 2008;17(3):137-49. doi: 10.3727/096504008785055549. Oncol Res. 2008. PMID: 18669165
Rituximab plus 70% cyclophosphamide, doxorubicin, vincristine and prednisone for Japanese patients with diffuse large B-cell lymphoma aged 70 years and older.
Meguro A, Ozaki K, Sato K, Oh I, Fujiwara S, Hosonuma R, Sasazaki M, Kikuchi Y, Hirata Y, Yamamoto C, Uesawa M, Kobayashi H, Matsu H, Okabe H, Uehara E, Nishikawa A, Tatara R, Hatano K, Yamamoto C, Matsuyama T, Toshima M, Ueda M, Ohmine K, Suzuki T, Mori M, Nagai T, Muroi K, Ozawa K. Meguro A, et al. Among authors: ohmine k. Leuk Lymphoma. 2012 Jan;53(1):43-9. doi: 10.3109/10428194.2011.600486. Epub 2011 Aug 24. Leuk Lymphoma. 2012. PMID: 21864040
Clinical features of de novo CD25(+) diffuse large B-cell lymphoma.
Fujiwara S, Muroi K, Hirata Y, Sato K, Matsuyama T, Ohmine K, Suzuki T, Ozaki K, Mori M, Nagai T, Tanaka A, Ozawa K. Fujiwara S, et al. Among authors: ohmine k. Hematology. 2013 Jan;18(1):14-9. doi: 10.1179/1607845412Y.0000000024. Epub 2012 Sep 12. Hematology. 2013. PMID: 22981118
Clinical features of de novo CD25-positive follicular lymphoma.
Fujiwara S, Muroi K, Tatara R, Matsuyama T, Ohmine K, Suzuki T, Mori M, Nagai T, Tanaka A, Ozawa K. Fujiwara S, et al. Among authors: ohmine k. Leuk Lymphoma. 2014 Feb;55(2):307-13. doi: 10.3109/10428194.2013.806658. Epub 2013 Jun 21. Leuk Lymphoma. 2014. PMID: 23697843
127 results